Go Deep
PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 25,246 | 81.0 | 0.83 | 0.20 | 181.00 |
PhoenixBio Co., Ltd. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 258,954,000.0 | 364,820,000.0 | 444,360,000.0 | 356,099,000.0 |
| Net Profit | -91,081,000.0 | 32,012,000.0 | 80,909,000.0 | -6,886,000.0 |
| EPS | -22.4 | — | — | — |
PhoenixBio Co., Ltd. Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 1,565,532,000.0 | 1,541,388,000.0 | 1,715,321,000.0 | 2,124,051,000.0 |
| Net Profit | 125,228,000.0 | -448,933,000.0 | 26,378,000.0 | 493,329,000.0 |
| EPS | 30.8 | -110.8 | 7.0 | 145.2 |
PhoenixBio Co., Ltd. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 2,192,682,000.0 | 2,285,342,000.0 | 2,715,320,000.0 | 3,018,661,000.0 | — |
| Total Liabilities | 640,055,000.0 | 919,936,000.0 | 917,713,000.0 | 1,504,189,000.0 | — |
| Total Equity | 1,552,627,000.0 | 1,365,406,000.0 | 1,797,607,000.0 | 1,514,472,000.0 | — |
PhoenixBio Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 52.4%Receivables 6.2%Inventory 14.0%Fixed assets (tangible) 23.6%Intangible assets 0.7%Other assets 2.6%
How it's funded — Mar 2026
Short-term debt 8.7%Long-term debt 6.4%Payables 0.6%Other liabilities 13.5%Shareholders' equity 70.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,148.2 | 1,150.0 | 1,385.1 | 1,555.3 |
| Receivables | 136.1 | 170.3 | 217.4 | 286.7 |
| Inventory | 307.8 | 333.2 | 450.6 | 365.2 |
| Fixed assets (tangible) | 518.4 | 527.7 | 542.9 | 538.5 |
| Intangible assets | 15.0 | 18.3 | 10.9 | 5.2 |
| Long-term investments | 10.0 | 9.4 | 9.5 | 125.5 |
| Other assets | 57.3 | 76.5 | 98.8 | 142.1 |
| Liabilities & equity | ||||
| Short-term debt | 190.0 | 180.0 | 180.0 | 875.0 |
| Long-term debt | 140.0 | 220.0 | 300.0 | 0.0 |
| Payables | 13.6 | 16.4 | 12.9 | 40.0 |
| Other liabilities | 296.4 | 503.6 | 424.8 | 589.2 |
| Shareholders' equity | 1,552.6 | 1,365.4 | 1,797.6 | 1,514.5 |
| Net tangible assets | 1,537.7 | 1,347.1 | 1,786.7 | 1,509.2 |
PhoenixBio Co., Ltd. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 68,857,000.0 | -73,000,000.0 | -79,307,000.0 | 277,491,000.0 | — |
| Investing Activities | -13,746,000.0 | -27,985,000.0 | 115,358,000.0 | -156,340,000.0 | — |
| Financing Activities | -88,009,000.0 | -128,000,000.0 | -244,879,000.0 | 86,630,000.0 | — |